Pharmacist Jobs In Singapore
Parkway Health (Singapore, Singapore)
Jurong Health Services (Singapore, Singapore)
1. Barnett A. Revealed: how drug firms ‘hoodwink’ medical journals. 2003. Available from: http://observercouk/uk_news/story/0,6903,1101680,00html. [Last accessed in 2007 Apr]
2. Bhopal R, Rankin J, McColl E, Thomas L, Kaner E, Stacy R, et al. The vexed question of authorship: views of researchers in a British medical faculty. BMJ. 1997;314:1009–1012.[PMC free article][PubMed]
3. Chalmers I. Role of systematic reviews in detecting plagiarism: case of Asim Kurjak (Review) BMJ. 2006;333(7568):594–596.[PMC free article][PubMed]
4. Chaudhry S, Schroter S, Smith R, Morris J. Does declaration of competing interests affect reader perceptions? A randomised trial. BMJ. 2002;325:1391–1392.[PMC free article][PubMed]
5. Dawes K. Ghostwriters need to be more visible. BMJ. 2007;34:208.
6. ICMJE. II.A Authorship and Contributorship. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. 2006. Available from: http://www.icmje.org [Last accessed on 2007 May 2]
7. Flanagin A, Carey LA, Fontanarosa PB, Phillips SG, Pace BP, Lundberg GD, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222–224.[PubMed]
8. Fugh-Berman A. The Corporate Coauthor. J Gen Intern Med. 2005;20:546–548.[PMC free article][PubMed]
9. Gøtzsche PC, Hróbjartsson A, Johansen HK, Haahr MT, Altman DG, Chan A-W. Ghost Authorship in Industry-Initiated Randomised Trials. PloS Med. 2007;4:e535. doi: 10.1371/journal.pmed.0040535. [PMC free article][PubMed]
10. Griffin-Sobel JP. The status of peer review, (Editorial) Clin J Oncol Nursing. 2005;9:669.[PubMed]
11. Hamilton CW, Royer MS. AMWA position statement on the contributions of medical writers to scientific publications. AMWA Journal. 2003;18(1):13–16.
12. Hamilton CW, Jacobs A. Survey of AMWA and EMWA members who make substantial contributions to manuscripts (poster 3) AMWA Journal. 2006;21(2):50.
13. Healy D, Cattell D. Interface between authorship, industry and science in the domain of therapeutics. B J Psychiatry. 2003;183:22–27.[PubMed]
14. Healy DT. Transparency and trust figure for ghost written articles was misquoted, (Letter) BMJ. 2004;329:1345.[PMC free article][PubMed]
15. Holden C. Science publishing. The undisclosed background of a paper on depression treatment (News) Science. 2006;313:598.[PubMed]
16. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21(2):317–321.[PubMed]
17. Jirik K. How Great researchers Get By-lines, Get Paid and Get medicine in Trouble. 2000. Available from: http://www.bioethicsforum.org/plagiarism-in-medical-research.asp [Last accessed on 2007 Apr]
18. Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? BMJ. 2007;334:120–123.[PMC free article][PubMed]
19. Laine C. Exorcising Ghosts and Unwelcome Guests, (Editorial) Ann Intern Med. 2005;143(8):611–612.[PubMed]
20. Larkin M. Whose article is it anyway? Lancet. 1999;354:136.[PubMed]
21. Lenzer J. Whistleblower charges drug company with deceptive practices. BMJ. 2003;326:620.[PMC free article][PubMed]
22. Madsen S. Ghostwriters-hide your tracks, (Letter) BMJ. 2005. Available from: http://bmj.bmjjournals.com/cgi/eletters/330/7498/988-a [Last accessed in 2007 Apr]
23. Moffatt B, Elliott C. Ghost Marketing. Perspectives in Biology and Medicine. 2007;50:18–31.[PubMed]
24. Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanigan A, Yank V, et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002;287:2769–2771.[PubMed]
25. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, et al. VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 2006;31:1345–1355.[PubMed]
26. Rees S. Who actually wrote the research paper? How to find it out (Letter) BMJ. 2003. Available from: http://bmj.bmjjournals.com/cgi/eletters/326/7400/1202. [Last accessed in 2007 Apr]
27. Rennie D. When Authorship fails. A proposal to make contributors accountable. JAMA. 1997;278:579–585.[PubMed]
28. Select Committee on Health. House of Commons. Examination of witnesses (questions 180-199) Minutes of Evidence; London Oct 14, 2004. 2004. Available at: http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4101414.htm[Last accessed in 2007 Apr]
29. Sharp D. A ghostly crew (Letter) Lancet. 1998;351:1076.[PubMed]
30. Shashok K, Jacobs A. Who's watching whose ethics? Slanted reporting of the medical writer's role in the Neuropsychopharmacology-Cyberonics case. The Write Stuff. 2007;16(1):33–35.
31. Sykes JB, editor. The Concise Oxford Dictionary. Seventh edition. Bombay: Ox Uni Press; 1985. 1983, reprinted 1985.
32. Reidenberg JW. Unmasking ghost writers. Clin Pharmacol Ther. 2001;70(3):208–209.[PubMed]
33. WAME. Ghost Writing Initiated by Commercial Companies. WAME Policy Statements. 2005. Available from: http://www.wame.org/wamestmt.htm#ghost [Last accessed on 2007 May 2] [PMC free article][PubMed]
34. Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin. 2003;19(3):149–154.[PubMed]
35. Wilde Mathews A. At medical journals, paid writers play a big role. The Wall Street Journal. 2005. Available from: http://www.post-gazette.com/pg/pp/05347/621668.stm [Last accessed in 2007 Apr] [PubMed]
36. Woolley KL. Goodbye Ghostwriters! How To Work Ethically and Efþ ciently With Professional medical Writers. Chest. 2006a;130:921–923.[PubMed]
37. Woolley KL, Ely JA, Woolley MJ, Findlay L, Lynch FA, Choi Y, et al. Declaration of medical writing assistance in international peer-reviewed publications. JAMA. 2006b;296:932–934.[PubMed]